Concepedia

Author

Jan H. Rüschoff

University Hospital of ZurichORCID

Also Known As

Androniki Stavrou, J Rüschoff, J. Rüschoff, J.H. Rüschoff, Jan H. Rüschoff, Jan Hendrik Ruschoff, Jan Hendrik Rüschoff, Jan Rüschoff, Rudolf Aebersold, Rüschoff, Jan

104

Publications

2.5K

Citations

26

H-Index

69

Concepts

All Affiliations

University Hospital of ZurichUniversity of ZurichETH ZurichKantonsspital BadenPhilipps University of Marburg
JH

About

Jan H. Rüschoff is an author at University Hospital of Zurich specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

13

17

857

2

Health Sciences

2

2

59

3

Engineering

1

1

36

4

Natural Sciences

1

1

31

5

Public Health

1

1

13

Jan H. Rüschoff

×

39

Publications

2.3K

Citations

26

H-Index

YearCitations

Automated Gleason grading of prostate cancer tissue microarrays via deep learning

Eirini Arvaniti, Kim S. Fricker, Michaël Moret,

Scientific Reports

2018

418

Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer

Lena Cords, Stefanie Engler, Martina Haberecker,

Cancer Cell

2024

206

Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis

Ilaria Guccini, Ajinkya Revandkar, Mariantonietta D’Ambrosio,

Cancer Cell

2020

168

Phase 2 Trial of Single-agent Everolimus in Chemotherapy-naive Patients with Castration-resistant Prostate Cancer (SAKK 08/08)

Arnoud J. Templeton, Valérie Dutoit, Richard Cathomas,

European Urology

2013

129

Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)

Christian Rothermundt, Stefanie Hayoz, Arnoud J. Templeton,

European Urology

2014

121

Diagnostic Accuracy of Multiparametric MRI versus <sup>68</sup>Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer

Urs J. Muehlematter, Irene A. Burger, Anton S. Becker,

Radiology

2019

118

HER2/ErbB2 activates HSF1 and thereby controls HSP90 clients including MIF in HER2-overexpressing breast cancer

Rainer Schulz, Felix Streller, Andreas H. Scheel,

Cell Death and Disease

2014

101

What’s behind 68Ga-PSMA-11 uptake in primary prostate cancer PET? Investigation of histopathological parameters and immunohistochemical PSMA expression patterns

Jan H. Rüschoff, Daniela A. Ferraro, Urs J. Muehlematter,

European Journal of Nuclear Medicine and Molecular Imaging

2021

89

Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with <sup>68</sup>Ga-PSMA-11-PET

Daniela A. Ferraro, Jan H. Rüschoff, Urs J. Muehlematter,

Theranostics

2020

86

Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma

Svenja Bihr, Riuko Ohashi, Ariane L. Moore,

Neoplasia

2019

72

Page 1